Loading stock data…
$420.38-13.12 (-3.03%)
Humana Inc.
Humana Inc. in the Healthcare sector is trading at $420.38 with a market capitalization of $50.5B. Wall Street consensus targets $464.00 (24 analysts), implying a +10.4% move over the next 12 months. The stock is currently near its 52-week high of $456.50, remaining 41.1% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $40.87B↑ | $39.65B↑ | $32.52B↓ | $32.65B↑ | $32.39B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $1.15B↓ | $1.79B↑ | -$865.00M↓ | $302.00M↓ | $898.00M |
| Net Income | $694.00M↓ | $1.19B↑ | -$796.00M↓ | $195.00M↓ | $545.00M |
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, inclu...
Academic risk and quality models computed from HUM's own filings and price history, not from analyst opinion.
Weak: only 3 of 9 fundamental-health tests pass, which is the range associated with deteriorating fundamentals.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 46.1% reading.
Fama-French 5-factor market beta. The five factors explain 3% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-13.